This study validates the use of advanced MRI techniques to detect early axonal damage in multiple sclerosis (MS). The researchers demonstrate that acute axonal pathology occurs prior to overt demyelination, emphasizing its role as an initial event in disease progression.
The findings support MRI as a reliable tool for identifying early biomarkers of MS, potentially improving diagnostic timelines. Early detection of axonal injury may help tailor interventions aimed at preserving neuronal integrity and slowing disease progression. This approach underscores the importance of integrating neuroimaging with molecular studies to deepen understanding and management of neurodegenerative disorders like MS.
